Global Full-length Transcriptome Sequencing Supply, Demand and Key Producers, 2023-2029
The global Full-length Transcriptome Sequencing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Full-length Transcriptome Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Full-length Transcriptome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Full-length Transcriptome Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Full-length Transcriptome Sequencing total market, 2018-2029, (USD Million)
Global Full-length Transcriptome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Full-length Transcriptome Sequencing total market, key domestic companies and share, (USD Million)
Global Full-length Transcriptome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Full-length Transcriptome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Full-length Transcriptome Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Full-length Transcriptome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Eurofins Scientific, Azenta, LabCorp and BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Full-length Transcriptome Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Full-length Transcriptome Sequencing Market, By Region:
1. How big is the global Full-length Transcriptome Sequencing market?
2. What is the demand of the global Full-length Transcriptome Sequencing market?
3. What is the year over year growth of the global Full-length Transcriptome Sequencing market?
4. What is the total value of the global Full-length Transcriptome Sequencing market?
5. Who are the major players in the global Full-length Transcriptome Sequencing market?
6. What are the growth factors driving the market demand?
This report studies the global Full-length Transcriptome Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Full-length Transcriptome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Full-length Transcriptome Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Full-length Transcriptome Sequencing total market, 2018-2029, (USD Million)
Global Full-length Transcriptome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Full-length Transcriptome Sequencing total market, key domestic companies and share, (USD Million)
Global Full-length Transcriptome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Full-length Transcriptome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Full-length Transcriptome Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Full-length Transcriptome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Eurofins Scientific, Azenta, LabCorp and BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Full-length Transcriptome Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Full-length Transcriptome Sequencing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Total RNA
- Noncoding RNA
- Biomedical Field
- Non-medical Field
- Illumina
- Thermo Fisher Scientific
- Bio-Rad
- Agilent Technologies
- QIAGEN
- Eurofins Scientific
- Azenta
- LabCorp
- BGI Genomics
1. How big is the global Full-length Transcriptome Sequencing market?
2. What is the demand of the global Full-length Transcriptome Sequencing market?
3. What is the year over year growth of the global Full-length Transcriptome Sequencing market?
4. What is the total value of the global Full-length Transcriptome Sequencing market?
5. Who are the major players in the global Full-length Transcriptome Sequencing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Full-length Transcriptome Sequencing Introduction
1.2 World Full-length Transcriptome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Full-length Transcriptome Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Full-length Transcriptome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.3 China Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.4 Europe Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.5 Japan Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.6 South Korea Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.7 ASEAN Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.8 India Full-length Transcriptome Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Full-length Transcriptome Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Full-length Transcriptome Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.2 World Full-length Transcriptome Sequencing Consumption Value by Region
2.2.1 World Full-length Transcriptome Sequencing Consumption Value by Region (2018-2023)
2.2.2 World Full-length Transcriptome Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.4 China Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.5 Europe Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.6 Japan Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.7 South Korea Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.8 ASEAN Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.9 India Full-length Transcriptome Sequencing Consumption Value (2018-2029)
3 WORLD FULL-LENGTH TRANSCRIPTOME SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Full-length Transcriptome Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Full-length Transcriptome Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Full-length Transcriptome Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for Full-length Transcriptome Sequencing in 2022
3.3 Full-length Transcriptome Sequencing Company Evaluation Quadrant
3.4 Full-length Transcriptome Sequencing Market: Overall Company Footprint Analysis
3.4.1 Full-length Transcriptome Sequencing Market: Region Footprint
3.4.2 Full-length Transcriptome Sequencing Market: Company Product Type Footprint
3.4.3 Full-length Transcriptome Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Full-length Transcriptome Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Full-length Transcriptome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Full-length Transcriptome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Full-length Transcriptome Sequencing Consumption Value Comparison
4.2.1 United States VS China: Full-length Transcriptome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Full-length Transcriptome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Full-length Transcriptome Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
4.4 China Based Companies Full-length Transcriptome Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based Full-length Transcriptome Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
4.5 Rest of World Based Full-length Transcriptome Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Full-length Transcriptome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Total RNA
5.2.2 Noncoding RNA
5.3 Market Segment by Type
5.3.1 World Full-length Transcriptome Sequencing Market Size by Type (2018-2023)
5.3.2 World Full-length Transcriptome Sequencing Market Size by Type (2024-2029)
5.3.3 World Full-length Transcriptome Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Full-length Transcriptome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biomedical Field
6.2.2 Non-medical Field
6.3 Market Segment by Application
6.3.1 World Full-length Transcriptome Sequencing Market Size by Application (2018-2023)
6.3.2 World Full-length Transcriptome Sequencing Market Size by Application (2024-2029)
6.3.3 World Full-length Transcriptome Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Full-length Transcriptome Sequencing Product and Services
7.1.4 Illumina Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Full-length Transcriptome Sequencing Product and Services
7.2.4 Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Bio-Rad
7.3.1 Bio-Rad Details
7.3.2 Bio-Rad Major Business
7.3.3 Bio-Rad Full-length Transcriptome Sequencing Product and Services
7.3.4 Bio-Rad Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Recent Developments/Updates
7.3.6 Bio-Rad Competitive Strengths & Weaknesses
7.4 Agilent Technologies
7.4.1 Agilent Technologies Details
7.4.2 Agilent Technologies Major Business
7.4.3 Agilent Technologies Full-length Transcriptome Sequencing Product and Services
7.4.4 Agilent Technologies Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Agilent Technologies Recent Developments/Updates
7.4.6 Agilent Technologies Competitive Strengths & Weaknesses
7.5 QIAGEN
7.5.1 QIAGEN Details
7.5.2 QIAGEN Major Business
7.5.3 QIAGEN Full-length Transcriptome Sequencing Product and Services
7.5.4 QIAGEN Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 QIAGEN Recent Developments/Updates
7.5.6 QIAGEN Competitive Strengths & Weaknesses
7.6 Eurofins Scientific
7.6.1 Eurofins Scientific Details
7.6.2 Eurofins Scientific Major Business
7.6.3 Eurofins Scientific Full-length Transcriptome Sequencing Product and Services
7.6.4 Eurofins Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Eurofins Scientific Recent Developments/Updates
7.6.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.7 Azenta
7.7.1 Azenta Details
7.7.2 Azenta Major Business
7.7.3 Azenta Full-length Transcriptome Sequencing Product and Services
7.7.4 Azenta Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Azenta Recent Developments/Updates
7.7.6 Azenta Competitive Strengths & Weaknesses
7.8 LabCorp
7.8.1 LabCorp Details
7.8.2 LabCorp Major Business
7.8.3 LabCorp Full-length Transcriptome Sequencing Product and Services
7.8.4 LabCorp Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 LabCorp Recent Developments/Updates
7.8.6 LabCorp Competitive Strengths & Weaknesses
7.9 BGI Genomics
7.9.1 BGI Genomics Details
7.9.2 BGI Genomics Major Business
7.9.3 BGI Genomics Full-length Transcriptome Sequencing Product and Services
7.9.4 BGI Genomics Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BGI Genomics Recent Developments/Updates
7.9.6 BGI Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Full-length Transcriptome Sequencing Industry Chain
8.2 Full-length Transcriptome Sequencing Upstream Analysis
8.3 Full-length Transcriptome Sequencing Midstream Analysis
8.4 Full-length Transcriptome Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Full-length Transcriptome Sequencing Introduction
1.2 World Full-length Transcriptome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Full-length Transcriptome Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Full-length Transcriptome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.3 China Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.4 Europe Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.5 Japan Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.6 South Korea Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.7 ASEAN Full-length Transcriptome Sequencing Market Size (2018-2029)
1.3.8 India Full-length Transcriptome Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Full-length Transcriptome Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Full-length Transcriptome Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.2 World Full-length Transcriptome Sequencing Consumption Value by Region
2.2.1 World Full-length Transcriptome Sequencing Consumption Value by Region (2018-2023)
2.2.2 World Full-length Transcriptome Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.4 China Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.5 Europe Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.6 Japan Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.7 South Korea Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.8 ASEAN Full-length Transcriptome Sequencing Consumption Value (2018-2029)
2.9 India Full-length Transcriptome Sequencing Consumption Value (2018-2029)
3 WORLD FULL-LENGTH TRANSCRIPTOME SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Full-length Transcriptome Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Full-length Transcriptome Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Full-length Transcriptome Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for Full-length Transcriptome Sequencing in 2022
3.3 Full-length Transcriptome Sequencing Company Evaluation Quadrant
3.4 Full-length Transcriptome Sequencing Market: Overall Company Footprint Analysis
3.4.1 Full-length Transcriptome Sequencing Market: Region Footprint
3.4.2 Full-length Transcriptome Sequencing Market: Company Product Type Footprint
3.4.3 Full-length Transcriptome Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Full-length Transcriptome Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Full-length Transcriptome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Full-length Transcriptome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Full-length Transcriptome Sequencing Consumption Value Comparison
4.2.1 United States VS China: Full-length Transcriptome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Full-length Transcriptome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Full-length Transcriptome Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
4.4 China Based Companies Full-length Transcriptome Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based Full-length Transcriptome Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
4.5 Rest of World Based Full-length Transcriptome Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Full-length Transcriptome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Total RNA
5.2.2 Noncoding RNA
5.3 Market Segment by Type
5.3.1 World Full-length Transcriptome Sequencing Market Size by Type (2018-2023)
5.3.2 World Full-length Transcriptome Sequencing Market Size by Type (2024-2029)
5.3.3 World Full-length Transcriptome Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Full-length Transcriptome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biomedical Field
6.2.2 Non-medical Field
6.3 Market Segment by Application
6.3.1 World Full-length Transcriptome Sequencing Market Size by Application (2018-2023)
6.3.2 World Full-length Transcriptome Sequencing Market Size by Application (2024-2029)
6.3.3 World Full-length Transcriptome Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Full-length Transcriptome Sequencing Product and Services
7.1.4 Illumina Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Details
7.2.2 Thermo Fisher Scientific Major Business
7.2.3 Thermo Fisher Scientific Full-length Transcriptome Sequencing Product and Services
7.2.4 Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.3 Bio-Rad
7.3.1 Bio-Rad Details
7.3.2 Bio-Rad Major Business
7.3.3 Bio-Rad Full-length Transcriptome Sequencing Product and Services
7.3.4 Bio-Rad Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Recent Developments/Updates
7.3.6 Bio-Rad Competitive Strengths & Weaknesses
7.4 Agilent Technologies
7.4.1 Agilent Technologies Details
7.4.2 Agilent Technologies Major Business
7.4.3 Agilent Technologies Full-length Transcriptome Sequencing Product and Services
7.4.4 Agilent Technologies Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Agilent Technologies Recent Developments/Updates
7.4.6 Agilent Technologies Competitive Strengths & Weaknesses
7.5 QIAGEN
7.5.1 QIAGEN Details
7.5.2 QIAGEN Major Business
7.5.3 QIAGEN Full-length Transcriptome Sequencing Product and Services
7.5.4 QIAGEN Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 QIAGEN Recent Developments/Updates
7.5.6 QIAGEN Competitive Strengths & Weaknesses
7.6 Eurofins Scientific
7.6.1 Eurofins Scientific Details
7.6.2 Eurofins Scientific Major Business
7.6.3 Eurofins Scientific Full-length Transcriptome Sequencing Product and Services
7.6.4 Eurofins Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Eurofins Scientific Recent Developments/Updates
7.6.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.7 Azenta
7.7.1 Azenta Details
7.7.2 Azenta Major Business
7.7.3 Azenta Full-length Transcriptome Sequencing Product and Services
7.7.4 Azenta Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Azenta Recent Developments/Updates
7.7.6 Azenta Competitive Strengths & Weaknesses
7.8 LabCorp
7.8.1 LabCorp Details
7.8.2 LabCorp Major Business
7.8.3 LabCorp Full-length Transcriptome Sequencing Product and Services
7.8.4 LabCorp Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 LabCorp Recent Developments/Updates
7.8.6 LabCorp Competitive Strengths & Weaknesses
7.9 BGI Genomics
7.9.1 BGI Genomics Details
7.9.2 BGI Genomics Major Business
7.9.3 BGI Genomics Full-length Transcriptome Sequencing Product and Services
7.9.4 BGI Genomics Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BGI Genomics Recent Developments/Updates
7.9.6 BGI Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Full-length Transcriptome Sequencing Industry Chain
8.2 Full-length Transcriptome Sequencing Upstream Analysis
8.3 Full-length Transcriptome Sequencing Midstream Analysis
8.4 Full-length Transcriptome Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Full-length Transcriptome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Full-length Transcriptome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Full-length Transcriptome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Full-length Transcriptome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Full-length Transcriptome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Full-length Transcriptome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Full-length Transcriptome Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Full-length Transcriptome Sequencing Players in 2022
Table 12. World Full-length Transcriptome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Full-length Transcriptome Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Full-length Transcriptome Sequencing Player
Table 15. Full-length Transcriptome Sequencing Market: Company Product Type Footprint
Table 16. Full-length Transcriptome Sequencing Market: Company Product Application Footprint
Table 17. Full-length Transcriptome Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Full-length Transcriptome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Full-length Transcriptome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 23. China Based Full-length Transcriptome Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 29. World Full-length Transcriptome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Full-length Transcriptome Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Full-length Transcriptome Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Full-length Transcriptome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Full-length Transcriptome Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Full-length Transcriptome Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Full-length Transcriptome Sequencing Product and Services
Table 38. Illumina Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Full-length Transcriptome Sequencing Product and Services
Table 44. Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Bio-Rad Basic Information, Area Served and Competitors
Table 48. Bio-Rad Major Business
Table 49. Bio-Rad Full-length Transcriptome Sequencing Product and Services
Table 50. Bio-Rad Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Recent Developments/Updates
Table 52. Bio-Rad Competitive Strengths & Weaknesses
Table 53. Agilent Technologies Basic Information, Area Served and Competitors
Table 54. Agilent Technologies Major Business
Table 55. Agilent Technologies Full-length Transcriptome Sequencing Product and Services
Table 56. Agilent Technologies Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Agilent Technologies Recent Developments/Updates
Table 58. Agilent Technologies Competitive Strengths & Weaknesses
Table 59. QIAGEN Basic Information, Area Served and Competitors
Table 60. QIAGEN Major Business
Table 61. QIAGEN Full-length Transcriptome Sequencing Product and Services
Table 62. QIAGEN Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. QIAGEN Recent Developments/Updates
Table 64. QIAGEN Competitive Strengths & Weaknesses
Table 65. Eurofins Scientific Basic Information, Area Served and Competitors
Table 66. Eurofins Scientific Major Business
Table 67. Eurofins Scientific Full-length Transcriptome Sequencing Product and Services
Table 68. Eurofins Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Eurofins Scientific Recent Developments/Updates
Table 70. Eurofins Scientific Competitive Strengths & Weaknesses
Table 71. Azenta Basic Information, Area Served and Competitors
Table 72. Azenta Major Business
Table 73. Azenta Full-length Transcriptome Sequencing Product and Services
Table 74. Azenta Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Azenta Recent Developments/Updates
Table 76. Azenta Competitive Strengths & Weaknesses
Table 77. LabCorp Basic Information, Area Served and Competitors
Table 78. LabCorp Major Business
Table 79. LabCorp Full-length Transcriptome Sequencing Product and Services
Table 80. LabCorp Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LabCorp Recent Developments/Updates
Table 82. BGI Genomics Basic Information, Area Served and Competitors
Table 83. BGI Genomics Major Business
Table 84. BGI Genomics Full-length Transcriptome Sequencing Product and Services
Table 85. BGI Genomics Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Full-length Transcriptome Sequencing Upstream (Raw Materials)
Table 87. Full-length Transcriptome Sequencing Typical Customers
Table 1. World Full-length Transcriptome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Full-length Transcriptome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Full-length Transcriptome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Full-length Transcriptome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Full-length Transcriptome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Full-length Transcriptome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Full-length Transcriptome Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Full-length Transcriptome Sequencing Players in 2022
Table 12. World Full-length Transcriptome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Full-length Transcriptome Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Full-length Transcriptome Sequencing Player
Table 15. Full-length Transcriptome Sequencing Market: Company Product Type Footprint
Table 16. Full-length Transcriptome Sequencing Market: Company Product Application Footprint
Table 17. Full-length Transcriptome Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Full-length Transcriptome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Full-length Transcriptome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 23. China Based Full-length Transcriptome Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Full-length Transcriptome Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Full-length Transcriptome Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Full-length Transcriptome Sequencing Revenue Market Share (2018-2023)
Table 29. World Full-length Transcriptome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Full-length Transcriptome Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Full-length Transcriptome Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Full-length Transcriptome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Full-length Transcriptome Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Full-length Transcriptome Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Full-length Transcriptome Sequencing Product and Services
Table 38. Illumina Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Full-length Transcriptome Sequencing Product and Services
Table 44. Thermo Fisher Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Bio-Rad Basic Information, Area Served and Competitors
Table 48. Bio-Rad Major Business
Table 49. Bio-Rad Full-length Transcriptome Sequencing Product and Services
Table 50. Bio-Rad Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Recent Developments/Updates
Table 52. Bio-Rad Competitive Strengths & Weaknesses
Table 53. Agilent Technologies Basic Information, Area Served and Competitors
Table 54. Agilent Technologies Major Business
Table 55. Agilent Technologies Full-length Transcriptome Sequencing Product and Services
Table 56. Agilent Technologies Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Agilent Technologies Recent Developments/Updates
Table 58. Agilent Technologies Competitive Strengths & Weaknesses
Table 59. QIAGEN Basic Information, Area Served and Competitors
Table 60. QIAGEN Major Business
Table 61. QIAGEN Full-length Transcriptome Sequencing Product and Services
Table 62. QIAGEN Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. QIAGEN Recent Developments/Updates
Table 64. QIAGEN Competitive Strengths & Weaknesses
Table 65. Eurofins Scientific Basic Information, Area Served and Competitors
Table 66. Eurofins Scientific Major Business
Table 67. Eurofins Scientific Full-length Transcriptome Sequencing Product and Services
Table 68. Eurofins Scientific Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Eurofins Scientific Recent Developments/Updates
Table 70. Eurofins Scientific Competitive Strengths & Weaknesses
Table 71. Azenta Basic Information, Area Served and Competitors
Table 72. Azenta Major Business
Table 73. Azenta Full-length Transcriptome Sequencing Product and Services
Table 74. Azenta Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Azenta Recent Developments/Updates
Table 76. Azenta Competitive Strengths & Weaknesses
Table 77. LabCorp Basic Information, Area Served and Competitors
Table 78. LabCorp Major Business
Table 79. LabCorp Full-length Transcriptome Sequencing Product and Services
Table 80. LabCorp Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. LabCorp Recent Developments/Updates
Table 82. BGI Genomics Basic Information, Area Served and Competitors
Table 83. BGI Genomics Major Business
Table 84. BGI Genomics Full-length Transcriptome Sequencing Product and Services
Table 85. BGI Genomics Full-length Transcriptome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 86. Global Key Players of Full-length Transcriptome Sequencing Upstream (Raw Materials)
Table 87. Full-length Transcriptome Sequencing Typical Customers
LIST OF FIGURES
Figure 1. Full-length Transcriptome Sequencing Picture
Figure 2. World Full-length Transcriptome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Full-length Transcriptome Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. Full-length Transcriptome Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Full-length Transcriptome Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Full-length Transcriptome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Full-length Transcriptome Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Full-length Transcriptome Sequencing Markets in 2022
Figure 27. United States VS China: Full-length Transcriptome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Full-length Transcriptome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Full-length Transcriptome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Full-length Transcriptome Sequencing Market Size Market Share by Type in 2022
Figure 31. Total RNA
Figure 32. Noncoding RNA
Figure 33. World Full-length Transcriptome Sequencing Market Size Market Share by Type (2018-2029)
Figure 34. World Full-length Transcriptome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Full-length Transcriptome Sequencing Market Size Market Share by Application in 2022
Figure 36. Biomedical Field
Figure 37. Non-medical Field
Figure 38. Full-length Transcriptome Sequencing Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Full-length Transcriptome Sequencing Picture
Figure 2. World Full-length Transcriptome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Full-length Transcriptome Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Full-length Transcriptome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Full-length Transcriptome Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. Full-length Transcriptome Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Full-length Transcriptome Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Full-length Transcriptome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Full-length Transcriptome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Full-length Transcriptome Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Full-length Transcriptome Sequencing Markets in 2022
Figure 27. United States VS China: Full-length Transcriptome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Full-length Transcriptome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Full-length Transcriptome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Full-length Transcriptome Sequencing Market Size Market Share by Type in 2022
Figure 31. Total RNA
Figure 32. Noncoding RNA
Figure 33. World Full-length Transcriptome Sequencing Market Size Market Share by Type (2018-2029)
Figure 34. World Full-length Transcriptome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Full-length Transcriptome Sequencing Market Size Market Share by Application in 2022
Figure 36. Biomedical Field
Figure 37. Non-medical Field
Figure 38. Full-length Transcriptome Sequencing Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
